Hypoxia as a therapy for mitochondrial disease
Defects in the mitochondrial respiratory chain (RC) underlie a spectrum of human conditions, ranging from devastating inborn errors of metabolism to aging. We performed a genome-wide Cas9-mediated screen to identify factors that are protective during RC inhibition. Our results highlight the hypoxia...
Main Authors: | Jain, I. H., Zazzeron, L., Goli, R., Alexa, K., Schatzman-Bone, S., Dhillon, H., Goldberger, O., Peng, J., Goessling, W., Zapol, W. M., Mootha, V. K., Shalem, Ophir, Sanjana, Neville E, Zhang, Feng |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Published: |
American Association for the Advancement of Science (AAAS)
2017
|
Online Access: | http://hdl.handle.net/1721.1/112720 https://orcid.org/0000-0003-2782-2509 |
Similar Items
-
High-throughput functional genomics using CRISPR–Cas9
by: Shalem, Ophir, et al.
Published: (2016) -
Improved vectors and genome-wide libraries for CRISPR screening
by: Sanjana, Neville E, et al.
Published: (2017) -
Mitochondrial dysfunction remodels one-carbon metabolism in human cells
by: Bao, Xiaoyan Robert, et al.
Published: (2016) -
Hypoxia-selective compounds for boron neutron capture therapy
by: Shah, Jungal (Jugal Kaushik)
Published: (2009) -
Selective thrombosis of tumor for enhanced hypoxia-activated prodrug therapy
by: Ma, Zhaoyu, et al.
Published: (2022)